Buscopan and Gemcitabine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Buscopan and Gemcitabine. Common interactions include arthralgia among females and cerebellar infarction among males.

The phase IV clinical study analyzes what interactions people who take Buscopan and Gemcitabine have. It is created by eHealthMe based on reports of 23 people who take Buscopan and Gemcitabine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 19, 2022

23 people who take Buscopan and Gemcitabine together, and have interactions are studied.


What is Buscopan?

Buscopan has active ingredients of hyoscine butylbromide. eHealthMe is studying from 4,771 Buscopan users for its effectiveness, alternative drugs and more.

What is Gemcitabine?

Gemcitabine has active ingredients of gemcitabine. eHealthMe is studying from 23,262 Gemcitabine users for its effectiveness, alternative drugs and more.

Number of Buscopan and Gemcitabine reports submitted per year:

Buscopan and Gemcitabine drug interactions.

Common Buscopan and Gemcitabine drug interactions by gender *:

female:

  1. Arthralgia
  2. Constipation
  3. Fatigue
  4. Gastroenteritis norovirus
  5. Gastrointestinal infection
  6. Head discomfort
  7. Mucosal inflammation
  8. Nausea
  9. Neutropenia
  10. Pain in extremity

male:

  1. Cerebellar infarction
  2. Urinary tract infection
  3. Abdominal infection
  4. Blood alkaline phosphatase increased
  5. Blood creatinine increased
  6. Dizziness
  7. Gastrointestinal perforation
  8. Haemoglobin decreased
  9. Intestinal obstruction
  10. Melaena

Common Buscopan and Gemcitabine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cerebellar infarction
  2. Urinary tract infection
  3. Bronchitis
  4. Infection
  5. Abdominal pain
  6. Blood alkaline phosphatase increased
  7. Blood creatinine increased
  8. Dizziness
  9. Haemoglobin decreased
  10. Malaise

50-59:

  1. Acute coronary syndrome
  2. Myocarditis

60+:

  1. Arthralgia
  2. Constipation
  3. Rash
  4. Subclavian vein thrombosis
  5. Mucosal infection
  6. Pain
  7. Pancreatic carcinoma
  8. Decreased appetite
  9. Diarrhoea
  10. Ileus

Common conditions people have *:

  1. Pain: 6 people, 26.09%
  2. Nausea (feeling of having an urge to vomit): 6 people, 26.09%
  3. Abdominal Pain: 5 people, 21.74%
  4. Constipation: 5 people, 21.74%
  5. Pancreatic Carcinoma (pancreatic cancer): 5 people, 21.74%
  6. Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 4 people, 17.39%
  7. Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 4 people, 17.39%
  8. Abdominal Pain Upper: 2 people, 8.70%
  9. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 8.70%
  10. Breast Cancer: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Buscopan and Gemcitabine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Buscopan and Gemcitabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Buscopan interactions:

Browse all interactions between Buscopan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Gemcitabine interactions:

Browse all interactions between Gemcitabine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hyoscine butylbromide and gemcitabine (the active ingredients of Buscopan and Gemcitabine, respectively), and Buscopan and Gemcitabine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Buscopan and Gemcitabine.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: